The Quality of Well-being (QWB) Scale combines preference-weighted measures of symptoms and functioning to provide a numerical point in-time expression of well-being that ranges from zero (0) for death to 1.0 for asymptomatic optimum functioning.
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some of the strengths and weaknesses of little or no impact on mortality rates, and general health outcome measures and conimportant illnesses, such as arthritis, have siders the issue of general versus diseaserelatively little relationship to mortaIity. specific measures within clinical populations. Morbidity
Measurement of Health Status
The most common approach to health status assessment is to measure morbidity in The conceptualization and measurement terms of function or role performance. For of health status has interested scholars for example, morbidity estimates often include many decades. Following the Eisenhower work days missed or bed disability days. administration, a President's Commission Many different approaches to health status on National Goals identified health status assessment using morbidity indicators have measurement as an important objective, been introduced. These include, for examShortly after, John Kenneth Galbraith, in pie, the Sickness Impact Profile (SIP) _ which The Affluent Society, described the need to represents the effect of disease or disability measure the effect of the health care system upon a variety of categories of behavioral on "quality of life." Recent years have seen function, and the RAND health status meamany attempts to define and measure sures, which have separate categories for health status. 1-3 Before considering any spethe effects of disease or health states upon cific approach, it is worth noting that tradiphysical function, social function, and tiona[ indicators of "health" have wellmental function. These measures do not inidentified problems, tegrate morbidity and mortality, although as each birth cohort ages, mortality cases acMortality true.
Death is a health outcome, and it is imMortality remains the major outcome portant that this outcome not be excluded measure in most epidemiologic studies and from any expression of health status. For clinical trials. Typically, mortality is exexample, suppose we were evaluating the pressed in a unit of time. For mortality data effect of Program A, integrated support and to be meaningful, they must be expressed as treatment, against that of Program B, no a rate, that is the proportion of deaths from support or treatment, for randomly assigned a particular cause occurring in some defined groups of very ill, elderly, nursing home restime interval (usually a year). Mortality rates idents. Let us suppose that Program A are often age-adjusted.
Case fatality rates maintained patients at a low level of funcexpress the proportion of persons who died lion throughout the year, but that in the of a particular disease divided by the total comparison group (Program B), the sickest number with the disease (including those 10% died. Looking just at the living in the who die and those who live). Reporting follow-up, one finds Program B patients to mortality rates has its advantages. They are be healthier, because the sickest had been "hard" data (despite some misclassification removed by death. By this standard, the bias *) and the meaning of the outcome is not program of no supportive treatment might difficult to comprehend.
Despite their many be put forth as the better alternative. With a advantages, mortality outcomes have some measure that combined morbidity and motobvious limitations. Mortality rates consider taIity the outcome would be very different, the dead and ignore the living. Many imbecause mortality effects would reduce the portant treatments or programs might have overall health of Program B to a low level. _
The Value Dimension year in pain is certainly worse than a day in pain. The final, and perhaps the most often Scholars have debated the components of neglected, factor is the value or preference "health" for many centuries, s Sullivan, in a associated withdifferent types of dysfuncreview of literature from various fields lion.
noted that most concepts of morbidity in- and rehabilitation, increase life expectancy. Second, the health Many programs affect the probability of occare system should improve the quality of currence of future dysfunction, rather than life during the years that people are alive. altering current functional status. In many Consider various measures in health care in aspects of preventive care, for example, the light of these two objectives. Traditional benefit of the treatment cannot be seen until biomedical indicators and diagnoses are immany years after the intervention.
A supportant to us because they may be related to portive family that instills proper health mortality or to quality of life. We prefer the habits in its children, for example, may also term health-related quality of life to refer to promote better health in the future, yet the the impact of health conditions on function. benefit may not be realized for years. The Thus, health-related quality of life may be concept of health must consider not only the independent of quality of life relevant to ability to function now but also the probawork setting, housing, air pollution, or simibility of future changes in function. A perlar factors. I' son who is very functional and asymptoNumerous quality-of-life measurement matic today may harbor a disease with a systems have evolved during the last 20 poor prognosis. Thus, many individuals are years. These systems are based primarily on at high risk of dying from heart disease even two different conceptual approaches. The though they are perfectly functional today, first approach grows out of the tradition of Should we call them "healthy?"
The term health status measurement. In the late "severity of illness" should take into consid1960s and early 1970s, the National Center eration both dysfunction and prognosis, Not uncommonly, experimental trials using them as "quality of life." These measures the psychometric approach will find that included the patients' subjective evaluation some aspects of quality of life improve of well-being, physical symptoms, sexual whereas others get worse. For example, a function, work performance and satisfacmedication might reduce high blood prestion, emotional status, cognitive function, sure but also be associated with headaches social participation, and life satisfaction, and impotence. The decision-theory apOther investigators, including Hunt and colproach attempts to place an overall value on leagues tr regard quality of Iife as subjective health status by weighting the different allappraisals of life satisfaction. [n summary, a mensions and combining them into an agwide variety of different dimensions has gregate quality score on the grounds that the been described as "quality of life." AIquality notion is the subjective evaluation of though agreement is lacking on which diobservable or obiective health states. It thus mensions should be considered the stanaims to provide an overall summary meadard for assessing quality of life in research sure of quality of life that integrates subjecstudies, recurrent themes in the methodlive function states, preferences for these o[ogic literature can assist in the evaluation states, morbidity, and mortality. of existing instruments.
Disease-Specific Versus General Measures Unidimensional Versus Multidimensional
Most health-related quality-of-life meaConstructs sures are designed for use with any populaAlthough all experts agree that quality of lion. Some investigators feel it is necessary Iife is a multidimensional construct, they to develop quality-of-life measures for spedebate whether outcome measures must cific diseases, such as cardiovascular disnecessarily represent this multidimensional ease. For •example, The RAND Corporation structure.
Quality-of-life assessment can Health Insurance Experiment has produced take essentially one of two major apa series of booklets describing the ¢onceptu-proaches: a psychometric approach and a alization and measurement of "physiologic 531 health." Each booklet describes the probrepresent different age groups and clinical lems in conceptualization and measurement characteristics: One group is from the center of a specific condition, such as coronary of the life span (acquired immune deficiency . heart disease, syndrome, or AIDS); one group is young The rationale underlying these measures (cystic fibrosis); and one group is older (aris largely, but not exclusively, clinicai and thritis). One group is characterized by clinisuggests that specific medical conditions cal outcomes that combine mortality and have very specific outcomes--an advantage morbidity (AIDS) whereas one group is to clinicians. For example, heart patients are characterized by high morbidity but low evaluated according to ejection fractions, mortality (arthritis). blood gases, etc. In addition to general The QWB Scale combines preferencephysiologic indicators, quality-of-life meaweighted measures of symptoms and funcsures are also designed specifically for partioning to provide a numerical point-in-time ticular disease groups. This is best repreexpression of weU-being that ranges from sented in the arthritis literature, where sevzero (0) for death to one (1.0) for asymptoeral measures have appeared in recent matic optimal functioning, i.e., higher scores years.Ls represent better health. Table 1 presents the In criticizing disease-specific approaches, symptom-problem complexes (CPX) and many investigators believe that all diseases their preference weights. Using these and disabilities affect overall quality of life.
symptoms does not require any assump-[n fact, the purpose of quality-of-life meat-ions either about the intensity or the durasurement is not to identify clinical information of the symptoms and problems, or lion relevant to the disease. Instead, it seeks about the underlying pathology. The meato determine the impact of the disease on sure simply indicates the symptom's presgeneral function. For example; a lower ejecence or absence on a given day. t-ion fraction may be associated with short-
The QWB has three function scales: mehess of breath, weakness, and increased risk bility (MOB), physical activity (PAC), and of mortality. Medications used to control social activity (SAC). Each step of these cardiovascular diseases might cause headscales has its own associated preference aches, irritability, and general confusion. By weight. These are recorded in Table 2 along focusing too specifically on clinical tortewith the single-day QWB calculating forlates of disease, it is argued, the general immula (Formula 1). In the General Health pact is overlooked. Conversely, general Policy Model (GHPM), the QWB inputs are quality-of-life measures adequately capture integrated with terms for the number of a wide variety of dysfunction associated people affected and the duration of time afwith cardiovascular diseases. This dysfuncfected to produce the output measure, lion might be in many different systems and which is known as the "well-year" (Forrecognized in symptoms such as confusion, mula 2).
tiredness, sexual impotence, and depresOver the last 15 years, operational comsion. These outcomes may not be specific to ponents have been defined for the GHPM the disease condition, to aid evaluation and resource allocation for any public issue concerning health. An early
The Quality of Well-being Scale conceptual paper demonstrated that wellyears are the necessary and final result of In this report, we apply a general healthapplying expected utility (decision) analysis related quality-of-Iife measure in three dinto treatments and policies. 1°The level of ical populations.
The clinical populations wellness at particular points (or over short $32 Step No.
Step Definition Weight syrup-(ARC). They were randomly assigned to retoms, and HIV neurologic diseases. The iraceive AZT treatment or placebo and were pact of HIV infection on functioning is evaluated using the QWB before beginning equally diverse. For example, HIV infection the trial and at eight follow-up visits over may result in fatigue, arthritis, blindness, the next 52 weeks. The value of the treatmemory loss, or paraplegia. Treatments for ment was estimated using the repeated measures analysis of variance (calculated HIV infection should be designed to prevent early mortality and to reduce morbidity using a general linear model). during periods before death.
The baseline characteristics of the subBecause of the major public health threat jects are given in Table 3 . The patients were associated with AIDS, efforts to find new divided into those with CD4 cell (also known as T, lymphocytes or T-helper cells) therapeutic approaches to manage this serious condition have been intense. In this counts less than or greater than 100 X 109/ section we report preliminary data using the L. Patients in both groups were comparable QWB system in an experimental trial evaluat baseline with regard to age, CD4 group, ating azidothymidine (AZT)" treatment for sex, diagnosis (AIDS or ARC), Karnofsky AIDS patients, score, and QWB (t-test and chi-square, P > .15). The mean initial CD4 count was sig-AZT has been available by prescription since September 1987. Its use in treating panificantly higher in the AZT group (P < .03). tients with advanced HIV infection is prediFor the QWB measure, the repeated meacared on the encouraging results of early sures analysis of variance (ANOVA) clinical trials. In the recently completed showed a significant effect of time (F 8/I72 mutticenter phase II AZT trial, 19 of 137 = 9.97, P < .0001). The interaction between placebo recipients died as compared with 1 group and time of testing (F 8/172 = 4.01, P < .0002), illustrated in Figure 1 , is • Azidothymidine (AZT) is also known by the gethe crucial component in evaluating treatneric name zidovudine (ZOV Clinical measures often include joint tenderthe values of the QWB is that it is not agehess, gTip strength; and joint circumference. specific; indeed, the associations appeared Some studies show that often the reliability to be equally strong for CF patients across of these measures is poor. 27 Fries 2s quesdifferent age groups. As with patients with tioned _he relevance and reliability of vatchronic obstructive pulmonary disease ious traditional outcome measures, indud-(COPD), the correlation between pulmoing laboratory measures of erythrocyte sedinary function and QWB score among CF mentation rate (ESR), latex fixation tiler, patients is substantial. The QWB was signifand hemoglobin, since rheumatoid arthritis icantly correlated with traditional outcome (RA) patients may develop serologic abhormeasures such as pulmonary function and realities that do not precisely coincide with exercise tolerance. However, the correlation joint inflammation.:9 In addition, Fries sugwas not perfect (r < 1.0), indicating that gested that traditional clinical measures QWB captures aspects of life quality in adsuch as grip strength, walking time, and padillon to pulmonary function. Pulmonary tient global assessment are merely surrofunction and exercise testing do provide ohgates for true outcome in arthritis, which, he jective measures of disease severity and proargued, are disability, physical discomfort, gression. However, they may not be sensiand financial loss. He asserted that pain and live to many other important aspects of the functional outcomes are most meaningful to disease and within the same level of pulmothe patients. Patients strive for extended life narv function, patients may show considerexpectancy and for improved function durable variability in their daily activities. ing the years they are alive. Laboratory findThese early data suggest that the QWB has ings may predict this dysfunction and are validity as an outcome measure in this speimportant only _or that reason. cific clinical population.
In clinical trials, CF-specific measures may also be used even though the use of a general measure allows Arthritis-specific measures the cost-utility for interventions in this paMost health-related quality-of-life meadent population to be compared with those sures developed before 1980 were designed for populations that suffer from different for use with any disease. Recently, some inclinical conditions, vestigators have promoted using diseaseArthritis specific quality-of-life measures, usually by combining a general measure with disease-,arthritis is the major cause of activity liraspecific measures. Nowhere is there a better itation in the United States. We consider arexample of this interplay than in research thritis in this report for two reasons. First, on rheumatoid arthritis. Investigators studyarthritis has relatively little impact upon ing new treatments for arthritis have develmortality in contrast to cystic fibrosis and oped a series of quality-of-life measures that 
Change in QWB vantage is that they may miss some imporclinical change. The group that received tant improvement that is specific for a parplacebo demonstrated essentiaily no change ticular population. Some observers also in the QWB scores, whereas the group rehave argued that general measures are less ceiving auranofin showed a mean improvesensitive to clinical change. Our data do not ment of 0.023; this difference was highly support this assertion. statistically significant P > .005. Auranofin
The general outcome measures appear to does not reach pharmacologically effective capture clinical change, as well as, if not levels for about 2 months, and QWB scores better than, disease-specific measures--a for the treatment and placebo groups begin distinct advantage. This observation apto diverge at about this time. Considering pears to be counter intuitive, but careful inthe many measures used in the trial, the spection of the QWB questions provides a percentage of variance accounted for with reasonable explanation. For example, an arthe QWB measure was among the more sigthritis patient who is unable to button his nificant. Traditional clinical measures, such shirt will need help with self-care. This paas the 50-foot walk and duration of morning tient may not see himself or herself as restiffness, were not statistically significant, quiring assistance but may be willing to although they did favor the auranofin admit to difficulty with the task. The subtle group. [n addition, simple self-ratings by differences are recognized better by the both patients and physicians failed to detect QWB than by disease-specific measures. the significant effect. However, a significant
The general measure may perform more network of associations emerged suggesting precisely because the questions have been that the QWB was associated with similar systematically studied and revised on the measures of general function. 3s basis of thousands of administrations with What is the clinical meaning of a differheterogeneous groups of patients and nonence of .023 on the QWB? A difference of patients. Our current results appear to con-KAPLANET AL.
MEDICAL CA_E trast with those of Liang and colleagues 3_ asymptomatic optimum functioning). Level who suggested that the QWB is less efficient of wellness at particular points in time are than the AIMS in detecting improvement in governed by the prognosis (transition rates pain level and function in patients with ator probabilities) generated by the underlythritis. However, the same authors found ing disease or injury. Well-years result from that the QWB was more efficient than sevintegrating the level of wellness, or healtheral other specific measures in detecting related quality of life over the life expecfunctional improvement on other global tancy. measures. Unfortunately, the Liang results The QWB system has been criticized beare difficult to interpret because the recause it has seen fewer clinical applications ported mean QWB score in this study was than have other health-related quality-of-33.3, a value that is theoretically impossible life measures. In this article, we suggest that to obtain, the QWBhas substantial potential for clini-A major advantage of the general apcaI research. In comparison to other meaproaches is that they allow the expression of sures, it may be more capable of generating program benefits in terms of well-year data that can be used in policy analysis, parunits. Using these common units, one can ticularly when comparisons across very. difcompare treatment interventions that are ferent treatment options are analyzed. very different from one another. For examHowever, because the QWB system is less pte, consider the impact of therapies for capable of pin pointing the specific aspects AIDS and arthritis. The treatment of rheuof function that are affected by diseases and matoid arthritis using auranofin produces a their treatments, the GHPM may be better net difference of about .023 QWB units per suited for comparisons between treatments patient. The mean difference between AZT or conditions that have different specific and placebo-treated AIDS patients was .47 objectives. It allows tradeoffs between risks QWB units at the final follow-up assessand benefits that are typically expressed in ment. To date, the AZT effect is the largest different units. Other measures such as the one observed in studies of medical, surgical, SIP may be better suited for helping clinior behavioral treatments. The treatment of clans identify which specific aspects of AIDS with AZT is also considerablv more function are affected by the disease or costly than the treatment of arthritis patreatment. tients with auranofin. Yet the duration of Considerably more research on the validthe benefit for arthritis patients may be ity, reliability, and generalizability of the longer and, over years, the discrepancy be-QWB system will be required. In particular, tween these two cases may diminish. At this the preference weighting system needs to be point, there are too few data to make further restandardized on a larger sample of redirect comparisons, spondents. Another problem that deserves This article describes some of our continugreater attention is identification of the aping work toward the development of a Genpropriate discount rate. Finally, we encoureral Health Policy Model (GHPM).
The age the development of general health-re-GHPM can be used for program evaluation, lated quality-of-life data in resources such population monitoring, clinical research, as the National Health Interview Survey and policy analysis. The QWB is an imporand the National Health and Nutrition Extant component of the model, in that it amination Survey. combines preference-weighted measures of symptoms and functioning to provide a nuEditor's note: For discussions related to these merical point-in-time expression of wellpoints, see the articles by Mulley, by Lipbeing ranging from 0 (for death) to 1.0 (for scomb, and by Erickson et al. in this issue.
